FDA Gives Mylan Tentative OK On Generic Femara
By Erik Larson · May 3, 2007, 12:00 AM EDT
Mylan Pharmaceuticals Inc. has moved closer to regulatory approval to make generic Femara, the drug maker said Thursday, raising the stakes in a patent infringement suit Germany's Novartis AG filed to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login